AXIM — Axim Biotechnologies Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Axim Biotechnologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-6.45	-6.41	-16	-6.24	-8.06
Depreciation
Amortisation
Non-Cash Items	1.65	2.69	11.5	2.73	2.07
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-0.231	0.486	-0.028	1.04	4.53
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-5.02	-3.22	-2.49	-2.04	-1.03
Capital Expenditures	—	-0.097	-0.051	-0.009	0
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.348	0.107	0	—	—
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	0.348	0.01	-0.051	-0.009	0
Financing Cash Flow Items	0	-0.158	0.007	-0.087	-0.027
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	3.38	3.15	2.53	1.65	1.14
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-1.29	-0.054	-0.004	-0.406	0.109